MedTrace Logo

HRV-based Training Effects in Athletes

NCT04150952 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2020-05-27

No results posted yet for this study

Summary

Monitoring individual responses to training is an important key factor to prescribe to most effective training programs. Heart-rate variability (HRV) could be used for monitoring the training status of endurance athletes in order to detect the fatigue status and to assess the adaptation to training. This direct fatigue measuring method has been little used to prescribe or regulate exercise prescription. Moreover, it allows new possibilities for the training load prescription according to an athlete's status, the response to the training load, and the adaptation to training. Regardless HRV-guided training, the athlete performance could also be influenced by precompetitive mood and anxiety, which can also be reflected in the precompetitive HRV scores and the subjective effort perception.

Conditions

  • Heart Rate Control
  • Athlete
  • Emotions

Interventions

OTHER

HRV-based training

Intervention based on HRV-guided training for the performance improvement of athletes. Pre-competitive HRV, subjective effort perception, anxiety and mood will also be analysed.

OTHER

TRAD training

Traditional endurance training

Sponsors & Collaborators

  • Universidad de Almeria

    lead OTHER

Principal Investigators

  • Alberto González Quílez, Master · Universidad de Almeria

  • Antonio Granero-Gallegos, PhD · Universidad de Almeria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-07
Primary Completion
2019-12-07
Completion
2019-12-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04150952 on ClinicalTrials.gov